细菌素
癌症
抗菌剂
行动方式
癌细胞
细胞毒性T细胞
癌细胞系
肽
癌症研究
生物
体外
药理学
医学
微生物学
毒理
内科学
生物化学
作者
Arnold Marshall Molujin,Sahar Abbasiliasi,Armania Nurdin,Ping Chin Lee,Jualang Azlan Gansau,Roslina Jawan
出处
期刊:Cancers
[MDPI AG]
日期:2022-09-29
卷期号:14 (19): 4758-4758
被引量:14
标识
DOI:10.3390/cancers14194758
摘要
Cancer is regarded as one of the most common and leading causes of death. Despite the availability of conventional treatments against cancer cells, current treatments are not the optimal treatment for cancer as they possess the possibility of causing various unwanted side effects to the body. As a result, this prompts a search for an alternative treatment without exhibiting any additional side effects. One of the promising novel therapeutic candidates against cancer is an antimicrobial peptide produced by bacteria called bacteriocin. It is a non-toxic peptide that is reported to exhibit potency against cancer cell lines. Experimental studies have outlined the therapeutic potential of bacteriocin against various cancer cell lines. In this review article, the paper focuses on the various bacteriocins and their cytotoxic effects, mode of action and efficacies as therapeutic agents against various cancer cell lines.
科研通智能强力驱动
Strongly Powered by AbleSci AI